Looksmaxxing › Leanmaxxing
Leanmaxxing
Body composition for the visual aesthetic.
Body fat percentage drives more aesthetic outcomes than any other variable — it determines vascularity, jawline definition, abdominal visibility, and overall shape.
This hub aggregates the compound stacks and protocols designed to drive aggressive (but sustainable) fat loss.
What it is
Compound classes:
- GLP-1 / GIP / glucagon agonists (semaglutide, retatrutide) — appetite + metabolic
- PPAR-delta agonists (cardarine) — fat oxidation
- Mitochondrial peptides (MOTS-c) — metabolic flexibility
- Muscle-preserving SARMs during deficit (LGD-4033, ostarine)
Featured Stacks
Comparisons
56 totalSurvodutide vs Retatrutide
Triple agonist vs dual: Retatrutide brings maximal fat loss, Survodutide shines for liver-fat targeting and thermogenic feel.
Mazdutide vs Tirzepatide
Glucagon/GLP-1 dual agonist for energetic fat-bias vs. GLP-1/GIP dual for max appetite control.
Retatrutide vs AOD-9604
Triple agonist metabolic sledgehammer vs. targeted lipolysis modulator.
Retatrutide vs Tirzepatide
Triple agonist vs dual: fat-loss ceiling, visceral/liver impact, and next-level appetite control.
Retatrutide vs Semaglutide
Triple-agonist firepower (Retatrutide) vs. proven, accessible GLP-1 (Semaglutide).
Survodutide vs Tirzepatide
Dual agonists for fat loss—Survodutide hits visceral fat harder, Tirzepatide delivers smoother appetite control.
Show 50 more comparisons
Mazdutide vs Semaglutide
GLP-1/glucagon dual agonist vs pure GLP-1: more fat loss, more hepatic clearance, different trade‑offs.
Mazdutide vs Survodutide
China's GLP-1/glucagon dual (mazdutide) vs. the West's frontrunner (survodutide): subtle differences in potency, titration, and real-world sourcing.
Retatrutide vs Mazdutide
Triple agonist vs dual agonist: unmatched raw loss vs balanced, proven recomp.
BAM15 vs AOD-9604
Tool uncoupler vs. targeted peptide: maximal mitochondrial burn or low-drama lipolysis.
Oleoylethanolamide vs Semaglutide
Endogenous lipid modulator vs. next-gen GLP-1 powerhouse: appetite control, risk, and real-world cutting utility.
Adipotide vs Semaglutide
Adipotide ejects stubborn fat via vascular targeting; semaglutide slashes appetite for long-haul cuts.
Orforglipron vs Retatrutide
Orforglipron: oral, flexible, runner-up efficacy. Retatrutide: triple-agonist injectable, next-level potency and fat loss.
Orforglipron vs Tirzepatide
Oral non-peptide GLP-1 (Orforglipron) convenience vs. unmatched dual-agonist potency (Tirzepatide).
Orforglipron vs Semaglutide
Oral daily GLP-1 (orforglipron) vs. gold-standard weekly injectable (semaglutide): convenience, ceiling, and real-world protocol tradeoffs.
Tesofensine vs Tirzepatide
Potent central appetite suppression (tesofensine) vs. unrivaled long-term fat loss (tirzepatide).
Tesofensine vs Retatrutide
Monoamine vs multi-incretin: classic SNDRI appetite crusher vs next-gen triple peptide power.
Oxandrolone vs Winstrol
Dry gains, two ways: var for clean strength, winny for etched grain.
Masteron vs Primobolan
Hard, dry detail (Masteron) vs. sustainable, clean gains (Primobolan).
Testosterone vs Masteron
Classic mass-builder vs the dry, chiseling finisher. Base cycle or contest polish?
Cardarine vs Ostarine
Endurance modulator vs. lean-mass preserver: cardio vs. muscle on a cut.
Retatrutide vs SLU-PP-332
Triple agonist vs. 'exercise in a vial' — fat loss by eating less or burning more?
Retatrutide vs Berberine
Triple agonist fat-loss peptide vs. the classic metabolic partitioner.
Tirzepatide vs Berberine
GLP-1/GIP dual agonist knockout stack versus the AMPK-powered workhorse.
Semaglutide vs AOD-9604
GLP-1 dominance vs targeted lipolytic support: maximal appetite suppression or mild fat-burn nudge?
Semaglutide vs Berberine
GLP-1 agonist vs. AMPK activator: maximal appetite suppression or metabolic support?
Retatrutide vs 5-Amino-1MQ
Maxed-out triple incretin fat loss vs. non-suppressive NAD+ partitioning.
Tirzepatide vs Semaglutide
Dual agonist vs. GLP-1: deeper fat loss, faster onset, different tolerability.
AOD-9604 vs Tesamorelin
Fat-biasing GH fragment vs. visceral-fat-shredding secretagogue — different axes, different targets.
Retatrutide vs MOTS-c
Triple agonist vs. mitochondrial mimetic—rapid fat loss or metabolic reprogramming?
Oleoylethanolamide vs Berberine
PPAR-α-driven appetite control vs. AMPK-driven metabolic partitioning.
Mirabegron vs BAM15
BAT activator with clean metabolic benefits vs mitochondrial uncoupler for serious fat loss.
Adipotide vs AOD-9604
Direct fat cell vasculature destruction (Adipotide) vs. mild, clean β3-driven lipolysis (AOD-9604).
Orforglipron vs Tesofensine
Oral GLP-1 agonist convenience vs. monoaminergic appetite power—two radically different approaches to weight loss.
Tesofensine vs Semaglutide
Tesofensine crushes food noise fast; semaglutide wins for safety and lean-mass retention.
p-Synephrine vs Yohimbine
β3 agonist vs α2 blocker: Peripheral thermogenesis meets stubborn-fat mobilization.
Winstrol vs Masteron
Winstrol is the dry, high-impact finisher; Masteron is the smooth, aesthetic hardener.
Oxandrolone vs Masteron
Oral var for versatile, mild cuts; mast for elite dryness and detail.
Oxandrolone vs Turinabol
Lean, dry orals—Anavar for safety, Turinabol for price and clean gains.
Oxandrolone vs Primobolan
Two classic dry compounds—one oral, one injectable. Distinct looks, cost, and sustainability.
Winstrol vs Turinabol
Winstrol sharpens the dry, hard look; Turinabol delivers steady, dry lean gains without the crash.
Equipoise vs Primobolan
EQ for slow, vascular lean mass; Primo for ultra-clean, low-side lean gains.
Testosterone vs Primobolan
Classic mass-builder vs. elite hardening agent — size, strength, and estrogen vs. dry, safe, and clean.
MOTS-c vs L-Carnitine
MOTS-c is your mitochondrial AMPK activator; L-carnitine shuttles fat to be burned. Different tools, different metabolic levers.
MOTS-c vs SLU-PP-332
Exercise-mimetic peptide vs. pan-ERR fat-burning small molecule.
MOTS-c vs 5-Amino-1MQ
Exercise-mimetic peptide vs. NAD+ pool-builder oral: two upstream paths to better metabolism and composition.
Tirzepatide vs AOD-9604
Maximum GLP-1 agonist power vs. clean, targeted lipolysis peptide.
5-Amino-1MQ vs SLU-PP-332
Two non-stim NAD⁺/mitochondrial enhancers for fat loss — partitioner vs pure mitochondrial drive.
Semaglutide vs 5-Amino-1MQ
Crush hunger with GLP-1 or shift calorie partitioning with NNMT inhibition.
Tirzepatide vs 5-Amino-1MQ
Two non-hormonal fat-loss tools: one crushes appetite, the other rewires metabolism.
HGH Fragment 176-191 vs Tesamorelin
Targeted fat loss vs. whole-body recomposition: pick by fat distribution, safety, and stack goals.
SR9011 vs Cardarine
SR9011: circadian clock modulator; Cardarine: gold-standard PPARδ agonist.
SR9011 vs Stenabolic
Two Scripps REV-ERB agonists. Nearly twin mechanisms, but different dosing and sourcing realities.
Cardarine vs Stenabolic
Endurance and conditioning, two ways: PPAR-δ (Cardarine) vs REV-ERB (Stenabolic).
AOD-9604 vs 5-Amino-1MQ
Targeted fat loss: peptide-driven lipolysis (AOD-9604) vs NNMT inhibition for calorie partitioning (5-Amino-1MQ).
HGH Fragment 176-191 vs AOD-9604
Two names, one peptide: minor sequence tweak, same real-world outcomes.
How to Start
If you're new to compounds, the Shredded Stack is overkill — start with diet + training. If you've plateaued and need leverage, the Shredded Stack is the proven aggressive option.